PHAS Annual FCF
-$50.09 M
+$11.27 M+18.37%
31 December 2021
Summary:
As of February 5, 2025, PHAS annual free cash flow is -$50.09 million, with the most recent change of +$11.27 million (+18.37%) on December 31, 2021. During the last 3 years, it has fallen by -$32.92 million (-191.72%).PHAS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAS Quarterly FCF
-$10.47 M
+$12.46 M+54.35%
30 June 2022
Summary:
As of February 5, 2025, PHAS quarterly free cash flow is -$10.47 million, with the most recent change of +$12.46 million (+54.35%) on June 30, 2022. Over the past year, it has increased by +$873.00 thousand (+7.70%).PHAS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAS TTM FCF
-$61.82 M
+$873.00 K+1.39%
30 June 2022
Summary:
As of February 5, 2025, PHAS TTM free cash flow is -$61.82 million, with the most recent change of +$873.00 thousand (+1.39%) on June 30, 2022. Over the past year, it has dropped by -$12.74 million (-25.96%).PHAS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAS Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.4% | +7.7% | -26.0% |
| 3 y3 years | -191.7% | +0.1% | -52.4% |
| 5 y5 years | -491.1% | - | -52.4% |
PHAS Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +491.1% | +296.6% | +2241.7% |
PhaseBio Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$10.47 M(-54.3%) | -$61.82 M(-1.4%) |
| Mar 2022 | - | -$22.93 M(+5.9%) | -$62.70 M(+25.2%) |
| Dec 2021 | -$50.09 M(-18.4%) | -$21.65 M(+219.8%) | -$50.09 M(+25.7%) |
| Sept 2021 | - | -$6.77 M(-40.3%) | -$39.84 M(-18.8%) |
| June 2021 | - | -$11.34 M(+9.8%) | -$49.08 M(+3.9%) |
| Mar 2021 | - | -$10.33 M(-9.4%) | -$47.22 M(-23.1%) |
| Dec 2020 | -$61.37 M(+51.3%) | -$11.40 M(-28.8%) | -$61.37 M(-2.0%) |
| Sept 2020 | - | -$16.00 M(+68.8%) | -$62.59 M(+13.3%) |
| June 2020 | - | -$9.48 M(-61.3%) | -$55.22 M(-1.8%) |
| Mar 2020 | - | -$24.48 M(+93.9%) | -$56.22 M(+38.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$40.55 M(+136.2%) | -$12.63 M(+46.2%) | -$40.55 M(+16.4%) |
| Sept 2019 | - | -$8.63 M(-17.6%) | -$34.85 M(+17.0%) |
| June 2019 | - | -$10.48 M(+18.9%) | -$29.80 M(+27.6%) |
| Mar 2019 | - | -$8.81 M(+27.3%) | -$23.35 M(+36.0%) |
| Dec 2018 | -$17.17 M(+102.6%) | -$6.93 M(+93.5%) | -$17.17 M(+67.6%) |
| Sept 2018 | - | -$3.58 M(-11.1%) | -$10.25 M(+53.7%) |
| June 2018 | - | -$4.03 M(+52.5%) | -$6.67 M(+152.5%) |
| Mar 2018 | - | -$2.64 M | -$2.64 M |
| Dec 2017 | -$8.47 M(-13.4%) | - | - |
| Dec 2016 | -$9.78 M | - | - |
FAQ
- What is PhaseBio Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals annual FCF year-on-year change?
- What is PhaseBio Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals quarterly FCF year-on-year change?
- What is PhaseBio Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals TTM FCF year-on-year change?
What is PhaseBio Pharmaceuticals annual free cash flow?
The current annual FCF of PHAS is -$50.09 M
What is the all time high annual FCF for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high annual free cash flow is -$8.47 M
What is PhaseBio Pharmaceuticals annual FCF year-on-year change?
Over the past year, PHAS annual free cash flow has changed by +$11.27 M (+18.37%)
What is PhaseBio Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of PHAS is -$10.47 M
What is the all time high quarterly FCF for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high quarterly free cash flow is -$2.64 M
What is PhaseBio Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, PHAS quarterly free cash flow has changed by +$873.00 K (+7.70%)
What is PhaseBio Pharmaceuticals TTM free cash flow?
The current TTM FCF of PHAS is -$61.82 M
What is the all time high TTM FCF for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high TTM free cash flow is -$2.64 M
What is PhaseBio Pharmaceuticals TTM FCF year-on-year change?
Over the past year, PHAS TTM free cash flow has changed by -$12.74 M (-25.96%)